Edwards Lifesciences Corp
Market cap $47.6B
$82.63
EW
$82.63
-1.42% today
Buy with €1M virtual cash · No real money
Edwards Lifesciences Corp (EW) is a publicly traded company listed on the XNYS. As of July 27, 2026, Invest's signal rates EW a Hold, with the stock up 7% over the past year. You can practice trading EW risk-free with €1,000,000 in virtual cash.
Key stats
As of July 27, 2026
Market Cap
$47.6B
Volume
10.5M
52-wk High
$96.29
52-wk Low
$72.30
Day High
$89.08
Day Low
$82.53
P/E (TTM)
43.95
Revenue (TTM)
$6.3B
EPS (TTM)
$1.88
Performance
1M
-7.8%
6M
-2.1%
1Y
+7.4%
Invest signal · EW
HoldAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
EW overview
AI overviewRevenue & EPS — last 8 quarters
QoQ rev +5.0%Revenue
$2BEPS (diluted)
$0.66 per shareLatest EW news
TRiCares Announces Initiation of TRICURE US IDE Pivotal Study for Topaz Tricuspid Valve Replacement System
GlobeNewswire Inc. · Jul 9
Edwards Lifesciences Stands Out As US Agency Eyes Broader Access For Heart Valve Device
Benzinga · Jun 16
Edwards Lifesciences Stock Surges On Heart Valve Devices Growth
Benzinga · Apr 24
ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing
The Motley Fool · Feb 20
Pulmonary Artery Catheter Market Size to Reach USD 1.97 Billion by 2035 Caused by the Surging Critical Care Procedures Globally
GlobeNewswire Inc. · Feb 17
About Edwards Lifesciences Corp
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Employees
16,000
30-Day Win Rate · EW
10 days
13 days
Last 23 sessions
How to practice trading EW
- 1
Use the EW buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top EW traders on Invest
Full leaderboardFrequently asked questions
Is EW a good stock to buy right now?
As of July 27, 2026, Invest's signal rates EW a Hold, based on its price trend, valuation, and fundamentals (P/E around 44.0), with the stock up 7% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading EW risk-free first.
What is Edwards Lifesciences Corp's (EW) market cap?
Edwards Lifesciences Corp has a market capitalization of approximately $47.6B, on trailing-twelve-month revenue of about $6.3B.
How has EW stock performed?
EW is up 7% over the past year and down 2% over six months. Its 52-week range runs roughly from $72.30 to $96.29. Past performance doesn't predict future results.
How can I practice trading EW for free?
On Invest you get €1,000,000 in virtual cash and can buy EW at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare EW with peers